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When an adequate amount of an antigenie
chemical such as dinitroehlorobenzene (DNCB)
is applied to the skin of a guinea pig, an allergic
contact sensitivity to that compound may re-
sult; this sensitivity is analogous to contact
sensitivity in man. After the appearance of
sensitization, however, further application of
the same chemical to the skin may eventually
produce a specific depression of sensitivity to
all, to study the phenomenon of topical hyposen-
sitization under controlled circumstances, and to
verify its existence. An additional goal was to
describe some of the prominent features of this
phenomenon in an attempt to achieve some
knowledge of its usefulness and with the hope of
gaining some insight into its underlying mecha-
nisms.
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METHOn5
Subjects were young adult male albino guinea
pigs, weighing 250—400 grams at the start of the
experiment.
Sensitization: Animals were sensitized to Tarac-
tan (chlorprothixene, a thioxanthene derivative
used as a "tranquilizer") by one or two intra-
dermal injections of 1.2 mg of the compound in
aqueous solution prepared for injection4 Sensiti-
zation to DNCB was accomplished by a single
application of 1 mg DNCB in acetonic solution to
the wax-epilated skin of the nape. These two sen-
sitization procedures were carried out several days
apart, and animals were sensitized to DNCB last,
in order to avoid interference phenomena.
Hyposensitization procedure: In studies of the
effects of repeated applications of antigen on sen-
sitivity, the antigen was dissolved in 0.1—0.2 ml of
the appropriate solvent and evenly applied to an
area approximately 5 X 3 cm on the right side
of the animal. This area was wax-epilated at
weekly intervals, or more often when necessary.
Hyposensitizing applications were made daily for
5 days a week.
Testing: For skin tests the antigen was applied
in the appropriate solvent to an area 1 em in di-
ameter on skin that had been wax-epilated 48
hours before. Sensitivity to a given antigen was
tested with at least 2 such tests. As a rule, 4 such
tests were made at one time, 2 to each of 2 anti-
gens. These 4 tests were placed at the corners of
an imaginary quadrangle on the side of the animal
so that the 2 tests with a given antigen were di-
agonally opposite to each other. By an unusual
coincidence, it was convenient to use 10 'y and 25
y of both antigens for test pairs. These doses
evoked no reaction in the unsensitized animal.
The tests were read at 12, 24, and 36 hours.
Each test was graded on the following scale;
0. No reaction.
0.5 Faint erythema.
1.0 Erythema of part of the test area.
2.0 Erythema of the whole area, or partial
erythema with induration.
3.0 Erythema and induration of the entire test
area.
As the tests were always given in pairs, the data
were simplified by adding the two test scores for
tabulation. This yielded an "intensity of reaction"
score for the antigen which could be as low as 0
or as high as 6.0 (e.g., two 3.0 tests).
Taraetan was generously supplied by Edward
Miller, M.D., of Hoffmann-La Roche, Inc. We
were fortunate in having a group of animals which
was very susceptible to sensitization with Tame-
tan; the sensitizing potency of this compound is
variable.
the compound. This second phenomenon is
known as topical hyposensitization; the term
"hardening" is sometimes used to refer to the
same phenomenon, particularly when the sensi-
tivity is occupational.
Topical hyposensitization with poison ivy
antigen (pentadecylcatechol) has been pro-
duced experimentally in man by Kligman (1).
In the guinea pig it has been reported by
Kobayashi (2), Landsteiner and Chase (3),
and Jadassohn, Brun, and Bujard (4). None of
these experimental studies was controlled to
rule out the possibility that non-specific effects
of prolonged administration of antigen and of
the resulting inflammation may have produced
a general lowering of sensitivity to all antigens,
rather than specific hyposensitization.
The following studies were designed, first of
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Experimental design: Thirty-two guinea pigs
were sensitized to both DNCB and Taractan,
given a preliminary test to verify sensitization,
and divided into the following three groups:
Group 1 (9 animals): Control animals subjected
only to sensitization and testing.
Group 2 (17 animals): Taractan, 100—1,000 'y
was applied to the wax-epilated skin of one
side 5 days a week for 10 weeks. Animals re-
ceiving different amounts (100 'y, 250 y, and
1,000 'y) of Tarnetan were combined into this
group as they showed identical trends.
Group 3 (6 animals): DNCB, 250 y, was applied
in the same way.
In all animals, sensitivity to both antigens was
measured by skin tests placed on the untreated
side at several points during the course of the ex-
periment; the first test was conducted after 2
weeks of treatment. In addition, identical tests
were placed on both sides, treated and untreated,
after the sixth week of treatment.
An important feature of the design of these ex-
periments is that the subjects were sensitized to 2
antigens, and that each of the 2 antigens was used
to produce hyposensitivity in one group. Experi-
ments in which "specific" depression is produced
by one antigen, while the other nntigen always
serves as control may lead to error. A variety of
non-specific factors may selectively depress the
reaction to one of two antigens, either because one
produces a "weaker" sensitivity than the other, or
because of differences in the sensitivity of the test-
ing methods. We have found, for instance that the
reaction to NDMA (p-nitrosodimethylaniline) is
more readily suppressed by non-specific agents
than is that to DNCB.
RESULTS
Specific hyposensitization was produced by
both DNCB and Taractan within the first
2 weeks of treatment. This is illustrated in
Figures 1 and 2. It must be noticed that in
Figure 1 the intensities of test reactions to
Taractan are presented; Figure 2 presents
the results of tests with DNCB, conducted at
the same times in the same animals. Both
figures are based on readings made 36 hours
after application of tests.
All but 2 of the 17 animals treated with
Taractan had total sensitivity scores be-
tween 0 and 2 when tested after 2 weeks'
treatment, while all but 2 of the 9 control
animals had scores in the 4 to 6 range. Statis-
tical analyses show that the specific depression
produced by Taractan was unquestionable. Al-
though only 6 animals were given DNCB, a
nonparametric test (Mann-Whitney U test)
shows that after 2 weeks' treatment the DNCB
reaction was significantly depressed compared
to that seen in controls (P = .015).
Another experiment of identical design was
conducted using DNCB and p-nitrosodimethyl-
aniline (NDMA) as antigens. This experiment,
which involved 42 animals, also showed specific
depression of the reaction to whichever antigen
was applied daily.
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FIG. 1. The mean intensities of test reactions to Taraetan are presented for the 3 groups of animals:
control animals, animals treated with DNCB, and animals treated with Taractan. Results of tests with
DNCB, conducted simultaneously, are presented in the other figure.
FIG. 2. The mean intensities of test reactions to DNCB are presented for the 3 groups of animals;
controls, animals treated with Taraetan, and those treated with DNCB. The animals were always tested
with Taractan simultaneously, and results of Taraetan tests are presented in Figure 1.
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Variability among antigens: Although hypo-
sensitization was always grossly apparent with
Taractan and NDMA, it was much more diffi-
cult to achieve with DNCB. With this anti-
gen, an occasional animal would always fail to
show the phenomenon, and the degree of de-
pression seen was less. When more than 1 mg
a day was given, non-specific depression of the
reaction to both antigens often appeared; with
less than this, hyposensitization might fail to
appear.
Inflammation at the site of treatment: When
DNCB or NDMA was applied daily to the
skin of a sensitized guinea pig, moderate to
severe inflammation developed which persisted
as long as the compound was applied. Although
the dose given was far below the irritant range,
this inflammation may have been due in part
to a cumulative irritant effect. When Taraetan
(which is not an irritant to the skin surface)
was used for hyposensitization, a moderate in-
flammation developed which reached its height
after about 2 weeks of treatment and then
slowly decreased. The area treated with Tarae-
tan was usually normal in appearance after
6—8 weeks' treatment. It is convenient to think
of the process of hyposensitization as a neutral-
ization reaction which takes place primarily
where the antigen is applied. A great deal of
visible inflammation results when the sensitivity
is strong, when the area treated is small, and
when a large amount of antigen is given at one
time. If the sensitivity is moderate, if the area
is large, and if the neutralization process is
extended in time, less inflammation will be
seen. This point was illustrated by another
experiment in which hyposensitization to Tar-
aetan was carried out by application to the
wax-epilated side of the animal of gradually
increasing doses of antigen, beginning with
25 y a day, and reaching 200—400 y after 3 weeks.
Only animals of moderate initial sensitivity
were included in the study. Under these cir-
cumstances, the amount of local inflammation
was reduced to an intermittent erythema, only
slightly redder than that seen in control animals
who were repeatedly wax-epilated, but not hypo-
sensitized.
"Lacal desensitization": On several occasions
in these experiments, animals were tested
simultaneously on both sides. This permits
comparison of the degree of hyposensitization
achieved in the distant skin and in the area
of daily application of the antigen. Although
the treated area of skin tended to be more
reactive to certain compounds, making the
difference between positive and negative tests
more striking, no valid evidence for "local
desensitization", such as was hypothesized by
Hunziker (5), was found.
Duration of depressed sensitivity: Although
the hyposensitizing procedure was stopped after
10 weeks in the experiment described, specific
depression of sensitivity was still obvious 5
weeks later (see Figures 1 and 2). In another
experiment, hyposensitization persisted for 2
months, at which time the experiment was
terminated.
At the end of the 5 week observation period
described above (15 weeks after hyposensitization
was begun), all animals were given an injec-
tion of 1.2 mg of Taractan emulsified in Freund's
adjuvant into one rear foot pad. Although
this was a more drastic procedure than that
originally used for sensitization, it did not re-
store—or even increase—sensitivity to Tarac-
tan in the hyposensitized animals. Two weeks
after the injection of Taractan described above,
the same animals were given 1 mg DNCB in
Frcund's adjuvant by the same route; again
no recovery of sensitivity was seen in the
hyposensitizcd animals. When the same animals
were later given 1 mg of NDMA (an antigen
to which they had not been previously sen-
sitized) in the same way, brisk sensitization oc-
curred; this suggests that the failure of the
hyposensitized animals to respond to further
sensitization procedures was due to their
prior experience with these antigens, and can-
not be attributed to a generalized deteriora-
tion of their immunologic machinery.
Attempts to prevent the appearance of
sensitivity: The mechanisms which underlie the
phenomena of topical hyposensitization are
unknown, but one simple hypothesis which de-
serves consideration is that the applied antigen
in some quantitative way "neutralizes" the sen-
sitivity of the animal. When the animal is fully
sensitized to start, there is a large reservoir of
sensitivity which must be neutralized by the topi-
cally applied antigen at a rate faster than that at
which "new" sensitivity can be generated (for the
same application of antigen that neutralizes may
also have a sensitizing effect).
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If this were all there is to it, then it should
he possible to prevent the appearance of a
positive skin test on untreated skin by be-
ginning the hyposensitizing treatment with the
first exposure to the compound, before sensi-
tivity has appeared. Under these circumstances,
it should be a simple matter to neutralize
the sensitivity as it appears, presumably arising
from a zero level, so that although inflammation
would be present at the treatment site, a posi-
tive test on normal skin would never appear.
Several such experiments were attempted,
using varying amounts of both NDMA and
DNCB as antigen. In a typical experiment,
500 y of NDMA was applied every day to the
skin of one group, while a control group re-
ceived a single sensitizing dose of NDMA. In
all experiments, the animals treated daily
with antigen developed higher sensitivity (as
measured by tests on untreated skin) than did
controls; in fact, daily application of antigen
is a very effective way to produce a high level
of sensitization.
It is paradoxical that hyposensitization oc-
curs at all—for the same series of exposures to
antigen which sensitizes the virgin animal has
the opposite effect of depressing sensitivity in
the animal which has already been sensitized.
Apparently the sensitization which results from
a first exposure to the antigen is so great that
it is virtually impossible to "neutralize" it
during the first days of sensitization; while in
the previously sensitized animal the same pro-
cedure produces less additional sensitization,
and hyposensitization can take place. Thus, the
process of contact sensitization in the guinea
pig subjected to repeated applications of anti-
gen appears to go through a phase of great
activity, followed by a period of relative re-
fractoriness to further contact sensitization.
This refractoriness may be due in part to
the continued bombardment with antigen which
is involved in the hyposensitization procedure,
or it may simply be part of the natural course
of contact sensitivity. Evidence to be presented
elsewhere suggests that the latter is the case:
After sensitization has been achieved the ani-
mal becomes relatively refractory to further
sensitization, and this is why topical application
of the antigen at that time can produce hypo-
sensitization instead of heightening the degree
of sensitivity.
5UMMARY
Specific depression of allergic contact sensi-
tivity can be produced in the previously sensi-
tized guinea pig by daily topical application
of small amounts of the antigen over a 2
week period. This is described with 2 antigens,
DNCB and Taractan, and is reported with a
third (NDMA). Such hyposensitization is more
readily accomplished with some sensitizers (e.g.,
Taractan, NDMA) than with others (e.g.,
DNCB).
During the early stages of hyposcnsitization,
sensitivity to the compound being applied is
depressed on untreated areas of skin, while in-
flammation occurs at the site of daily appli-
cation. In the case of Taraetan, inflammation
at the site of application may be transient or
mild.
After daily application of the antigen was
stopped, specific depression of sensitivity per-
sisted for at least 5 weeks. Sensitivity could not
be restored to hyposensitized animals by sen-
sitization procedures which arc usually quite
effective.
Hyposensitization procedures which effectively
depress sensitivity in the sensitized animal do
not prevent or delay appearance of sensitivity
following initial exposure to the antigen.
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